Discontinuation report REPATHA

Last updated on 2024-07-18 History
Report ID 223420
Drug Identification Number 02459779
Brand name REPATHA
Common or Proper name evolocumab injection
Company Name AMGEN CANADA INC
Market Status MARKETED
Active Ingredient(s) EVOLOCUMAB
Strength(s) 120MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 420 mg / 3.5 mL (AMD)
ATC code C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for discontinuation Business reasons
Anticipated discontinuation date 2024-12-31
Actual discontinuation date
Remaining supply date 2024-12-31
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6775 FINANCIAL DRIVE
MISSISSAUGA, ONTARIO
CANADA L5N 0A4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-07-18 French Compare
v9 2024-07-18 English Compare
v8 2024-06-20 French Compare
v7 2024-06-20 English Compare
v6 2024-05-24 French Compare
v5 2024-05-24 English Compare
v4 2024-03-26 French Compare
v3 2024-03-26 English Compare
v2 2024-03-26 French Compare
v1 2024-03-26 English Compare

Showing 1 to 10 of 10